Abstract:
A cyclotriphosphazene-platinum(II) conjugate is provided to show high selectivity on a cancer tissue and excellent anticancer effect due to excellent permeation-retention property effect on the cancer tissue. A cyclotriphosphazene-platinum(II) conjugate is represented by the formula(1), where n is 7, 12 or 16; m is 0, 1 or 2; x is 1; each y and z is respectively 0 or 1; and each R, R' and R' is respectively selected from the group consisting of (CH3)2CH-, (CH3)2CHCH2-, (C2H5)(CH3)CH- and (C6H5)CH2-; and A and A' are independently an amine monodendate or A and A' may bound to each other to form a chelate type diamine didendate. An anticancer composition comprises the cyclotriphosphazene-platinum(II) conjugate as an effective ingredient. A method for preparing the conjugate comprises the steps of: (a) hydrolyzing a cyclotriphosphazene represented by the formula(3) to prepare an alkali metal salt or an alkali earth metal salt thereof represented by the formula(4); and (b) coupling the compound of the formula(4) to a (diamine) platinum(II) complex represented by the formula(5), where the n, m, x, y, z, R, R', R", A and A' are same as defined above; M is two alkali metal ions selected from the group consisting of potassium ion and sodium ion or Ba^2+; and L is one or two anion ligand(s) selected from the group consisting of sulfuric acid ion and nitric acid ion.